Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Psychopharmacol. 2013 Aug 7;27(10):894–902. doi: 10.1177/0269881113499204

Table 3.

Unweighted means from the mixed model for distribution volume (VT) and binding potential (BPF) pre- and post-treatment. Means are given for the mixed model both with and without using Montgomery-Asberg Depression Rating Scale (MADRS) as a covariate.

BPF Without MADRS covariate
 With MADRS covariate
Pre-treatment Post-treatment Pre-treatment Post-treatment
LACC 38.463 44.729 40.576 44.896
RACC 38.743 45.457 40.855 45.031
LAI 41.855 48.937 43.967 48.388
RAI 42.406 49.085 44.519 48.647
LMTC 67.957 83.475a 70.070 83.920a
RMTC 67.280 77.953 69.393 79.239
LPCC 36.146 40.747 38.259 40.571
RPCC 33.925 38.885 36.038 38.964
LPOC 31.926 39.852 34.039 38.801
RPOC 32.747 38.653 34.860 37.952
Raphe 28.583 30.163 30.695 28.816
a

Indicates that post-treatment value is significantly different from pre-treatment value at p<0.05 after both false discovery rate (FDR) and Bonferroni correction for multiple comparisons.

LACC: left anterior cingulate cortex; LAI: left anterior insula; LMTC: left mesiotemporal cortex; LPCC: left posterior cingulate cortex; LPOC: left parieto-occipital cortex; MADRS: Montgomery-Asberg Depression Rating Scale; RACC: right anterior cingulate cortex; RAI: right anterior insula; RMTC: right mesiotemporal cortex; RPCC: right posterior cingulate cortex; RPOC: right parieto-occipital cortex.